Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.

Luther, James M; Gainer, James V; Murphey, Laine J; Yu, Chang; Vaughan, Douglas E; Morrow, Jason D; Brown, Nancy J

Luther, James M; Gainer, James V; Murphey, Laine J; Yu, Chang; Vaughan, Douglas E; Morrow, Jason D; Brown, Nancy J.

Affiliation

Luther JM; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA. james.luther@vanderbilt.edu

Hypertension ; 48(6): 1050-7, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17043157

Subject(s)

Angiotensin II/metabolism; Interleukin-6/metabolism; Oxidative Stress/drug effects; Receptors, Mineralocorticoid/metabolism; Adult; Aldosterone/administration & dosage; Cross-Over Studies; Diet, Sodium-Restricted; Double-Blind Method; Female; Humans; Hydroxycorticosteroids/administration & dosage; Infusions, Intravenous; Male; Mineralocorticoid Receptor Antagonists/pharmacology; Spironolactone/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin II / Interleukin-6 / Receptors, Mineralocorticoid / Oxidative Stress Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Hypertension Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links